189 related articles for article (PubMed ID: 29788419)
1. Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.
Belvis Jiménez M; Maldonado Pérez B; Argüelles-Arias F
J Crohns Colitis; 2018 Aug; 12(9):1134-1135. PubMed ID: 29788419
[No Abstract] [Full Text] [Related]
2. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
[No Abstract] [Full Text] [Related]
3. Sweet's syndrome in a patient with acute ulcerative colitis: presentation of a case and review of the literature.
Díaz-Peromingo JA; García-Suárez F; Sánchez-Leira J; Saborido-Froján J
Yale J Biol Med; 2001; 74(3):165-8. PubMed ID: 11501712
[No Abstract] [Full Text] [Related]
4. Sweet's syndrome and mucosal prolapse polyps in a male patient with ulcerative colitis.
Zhao X; Jiang S; Chen Y; Liu J; Liu J; Shi X
BMC Gastroenterol; 2021 Dec; 21(1):478. PubMed ID: 34915857
[TBL] [Abstract][Full Text] [Related]
5. Bullous Sweet's syndrome in a patient with ulcerative colitis: a rare case report.
Giannoni M; Rizzetto G; Sapigni C; Paolinelli M; Tagliati C; Diotallevi F; Campanati A; Mandolesi A; Pepi L; Offidani A
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Sep; 29(3):153-155. PubMed ID: 32975303
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis and Sweet's syndrome: a case report and review of the literature.
Ali M; Duerksen DR
Can J Gastroenterol; 2008 Mar; 22(3):296-8. PubMed ID: 18354759
[TBL] [Abstract][Full Text] [Related]
7. Co-treatment With Golimumab and Vedolizumab to Treat Severe UC and Associated Spondyloarthropathy.
Roblin X; Paul S; Ben-Horin S
J Crohns Colitis; 2018 Feb; 12(3):379-380. PubMed ID: 29088342
[No Abstract] [Full Text] [Related]
8. Infliximab as Rescue Treatment in Sweet's Syndrome Related to Corticodependent Ulcerative Colitis.
Moreno Márquez C; Maldonado Pérez B; Castro Laria L
J Crohns Colitis; 2018 May; 12(6):755-756. PubMed ID: 29474532
[No Abstract] [Full Text] [Related]
9. Resolution of CMV Infection in the Bowel on Vedolizumab Therapy.
Rawa-Gołębiewska A; Lenarcik M; Zagórowicz E
J Crohns Colitis; 2019 Sep; 13(9):1234-1235. PubMed ID: 30860256
[No Abstract] [Full Text] [Related]
10. [Sweet's syndrome and arthritis in a patient with ulcerative colitis].
Goikoetxea U; Eguiluz A; Lobo C; Cosme A; Ojeda E; Bujanda L
Gastroenterol Hepatol; 2007 Oct; 30(8):506-7. PubMed ID: 17949618
[No Abstract] [Full Text] [Related]
11. Recurrent COVID-19 in a Patient With Ulcerative Colitis on Vedolizumab Therapy.
Crouwel F; Waaijenberg-Warmenhoven P; Buiter HJC; de Boer NK
J Crohns Colitis; 2021 Jul; 15(7):1244-1245. PubMed ID: 33350449
[No Abstract] [Full Text] [Related]
12. Successful Vedolizumab Therapy in a Sixteen-Year-Old Boy with Refractory Ulcerative Colitis.
Zoet ID; de Boer NK; de Meij TG
J Crohns Colitis; 2016 Mar; 10(3):373-4. PubMed ID: 26574489
[No Abstract] [Full Text] [Related]
13. A rare case of bullous Sweet's syndrome in a patient with inactive ulcerative colitis.
Esposito I; Fossati B; Peris K; De Simone C
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e380-e381. PubMed ID: 31081562
[No Abstract] [Full Text] [Related]
14. Nodular vasculitis during treatment with vedolizumab in a patient with ulcerative colitis.
Abbenante D; Merli Y; Misciali C; Sacchelli L; Bardazzi F
Australas J Dermatol; 2022 Feb; 63(1):131-132. PubMed ID: 34817061
[No Abstract] [Full Text] [Related]
15. Vedolizumab for the treatment of ulcerative colitis.
Shahidi N; Bressler B; Panaccione R
Expert Opin Biol Ther; 2016; 16(1):129-35. PubMed ID: 26567768
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
McLean LP; Cross RK
Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):833-42. PubMed ID: 27096357
[TBL] [Abstract][Full Text] [Related]
17. Response to vedolizumab for children with steroid-refractory Ulcerative Colitis unresponsive to anti-TNF.
Wiskin AE; Paul SP; Spray CH
Acta Paediatr; 2019 Jul; 108(7):1359-1360. PubMed ID: 30788859
[No Abstract] [Full Text] [Related]
18. Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?
D'Amico F; Danese S; Peyrin-Biroulet L
Expert Opin Biol Ther; 2020 Apr; 20(4):353-361. PubMed ID: 31951748
[No Abstract] [Full Text] [Related]
19. A review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitis.
Tsai HH; Black C
Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):679-683. PubMed ID: 27726457
[TBL] [Abstract][Full Text] [Related]
20. Sweet's syndrome: a rare extraintestinal manifestation of ulcerative colitis.
Stevenson R; Hannay J
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27170614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
